SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cassidy JT, Petty RE. Textbook of pediatric rheumatology. 5th ed. New York: Elsevier; 2005.
  • 2
    Rapoff MA. Adherence to pediatric medical regimens. New York: Kluwer/Plenum; 1999.
  • 3
    Litt IF, Cuskey WR. Compliance with salicylate therapy in adolescents with juvenile rheumatoid arthritis. Am J Dis Child 1981; 135: 4346.
  • 4
    Litt IF, Cuskey WR, Rosenberg A. Role of self-esteem and autonomy in determining medication compliance among adolescents with juvenile rheumatoid arthritis. Pediatrics 1982; 69: 157.
  • 5
    Rapoff MA, Lindsley CB, Christophersen ER. Improving compliance with medical regimens: case study with juvenile rheumatoid arthritis. Arch Phys Med Rehabil 1984; 65: 2679.
  • 6
    Rapoff MA, Purviance MR, Lindsley CB. Improving medication compliance for juvenile rheumatoid arthritis and its effect on clinical outcome: a single-subject analysis. Arthritis Care Res 1988; 1: 126.
  • 7
    Rapoff MA, Purviance MR, Lindsley CB. Educational and behavioral strategies for improving medication compliance in juvenile rheumatoid arthritis. Arch Phys Med Rehabil 1988; 69: 43941.
  • 8
    Rapoff MA. Compliance with treatment regimens for pediatric rheumatic diseases. Arthritis Care Res 1989; 2: S407.
  • 9
    Chaney JM, Peterson L. Family variables and disease management in juvenile rheumatoid arthritis. J Pediatr Psychol 1989; 14: 389403.
  • 10
    Kyngas H. Motivation as a crucial predictor of good compliance in adolescents with rheumatoid arthritis. Int J Nurs Pract 2002; 8: 33641.
  • 11
    Urquhart J, de Klerk E. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. Stat Med 1998; 17: 25167.
  • 12
    Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49: 3217.
  • 13
    De Klerk E, van der Linden SJ. Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device. Br J Rheumatol 1996; 35: 605.
  • 14
    Rapoff MA, Belmont J, Lindsley C, Olson N, Morris J, Padur J. Prevention of nonadherence to nonsteroidal anti-inflammatory medications for newly diagnosed patients with juvenile rheumatoid arthritis. Health Psychol 2002; 21: 6203.
  • 15
    Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al. Current proposed revision of JRA criteria. Arthritis Rheum 1997; 20 Suppl 2: 1959.
  • 16
    Hollingshead AB. Four factor index of social status. New Haven (CT): Yale University; 1975.
  • 17
    Sackett DL, Snow JC. The magnitude of compliance and noncompliance. In: HaynesRB, TaylorDW, SackettDL, editors. Compliance in health care. Baltimore: The Johns Hopkins University Press; 1979. p. 1122.
  • 18
    Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr 2003; 33: 2118.
  • 19
    Bender B, Milgrom H, Rand C, Ackerson L. Psychological factors associated with medication nonadherence in asthmatic children. J Asthma 1998; 35: 34753.
  • 20
    Gibson NA, Ferguson AE, Aitchison TC, Paton JY. Compliance with inhaled asthma medication in preschool children. Thorax 1995; 50: 12749.
  • 21
    Bender B, Wamboldt FS, O'Connor SL, Rand C, Szefler S, Milgrom H, et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000; 85: 41621.
  • 22
    Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98: 10517.
  • 23
    Brownbridge G, Fielding DM. Psychosocial adjustment and adherence to dialysis treatment regimes. Pediatr Nephrol 1994; 8: 7449.
  • 24
    Hazzard A, Hutchinson SJ, Krawiecki N. Factors related to adherence to medication regimens in pediatric seizure patients. J Pediatr Psychol 1990; 15: 54355.
  • 25
    Bobrow ES, AvRuskin TW, Siller J. Mother-daughter interaction and adherence to diabetes regimens. Diabetes Care 1985; 8: 14651.
  • 26
    Patterson JM. Critical factors affecting family compliance with home treatment for children with cystic fibrosis. Fam Relations 1985; 34: 7989.
  • 27
    Radius SM, Becker MH, Rosenstock IM, Drachman RH, Schuberth KC, Teets KC. Factors influencing mothers' compliance with a medication regimen for asthmatic children. J Asthma Res 1978; 15: 13349.
  • 28
    Bradley RH, Corwyn RF. Socioeconomic status and child development. Annu Rev Psychol 2002; 53: 37199.
  • 29
    Chen E, Matthews KA, Boyce WT. Socioeconomic differences in children's health: how and why do these relationships change with age? Psychol Bull 2002; 128: 295329.
  • 30
    Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A 2002; 99: 1092934.
  • 31
    Gordis L. Conceptual and methodologic problems in measuring patient compliance. In: HaynesRB, TaylorDW, SackettDL, editors. Compliance in health care. Baltimore: The Johns Hopkins University Press; 1979. p. 2345.